[go: up one dir, main page]

WO2003010327A3 - Novel proteins and nucleic acids encoding same - Google Patents

Novel proteins and nucleic acids encoding same Download PDF

Info

Publication number
WO2003010327A3
WO2003010327A3 PCT/US2002/014199 US0214199W WO03010327A3 WO 2003010327 A3 WO2003010327 A3 WO 2003010327A3 US 0214199 W US0214199 W US 0214199W WO 03010327 A3 WO03010327 A3 WO 03010327A3
Authority
WO
WIPO (PCT)
Prior art keywords
small molecule
molecule target
nucleic acids
polynucleotide
acids encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/014199
Other languages
French (fr)
Other versions
WO2003010327A2 (en
Inventor
Charles E Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CuraGen Corp filed Critical CuraGen Corp
Priority to AU2002316064A priority Critical patent/AU2002316064A1/en
Publication of WO2003010327A2 publication Critical patent/WO2003010327A2/en
Anticipated expiration legal-status Critical
Publication of WO2003010327A3 publication Critical patent/WO2003010327A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment ofa broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases.
PCT/US2002/014199 2001-02-21 2002-05-02 Novel proteins and nucleic acids encoding same Ceased WO2003010327A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002316064A AU2002316064A1 (en) 2001-05-02 2002-05-02 Novel proteins and nucleic acids encoding same

Applications Claiming Priority (59)

Application Number Priority Date Filing Date Title
US35924501P 2001-02-21 2001-02-21
US28806301P 2001-05-02 2001-05-02
US60/288,063 2001-05-02
US28839501P 2001-05-03 2001-05-03
US60/288,395 2001-05-03
US28908701P 2001-05-07 2001-05-07
US60/289,087 2001-05-07
US28981701P 2001-05-09 2001-05-09
US28981801P 2001-05-09 2001-05-09
US60/289,817 2001-05-09
US60/289,818 2001-05-09
US29019401P 2001-05-11 2001-05-11
US60/290,194 2001-05-11
US29075301P 2001-05-14 2001-05-14
US60/290,753 2001-05-14
US29118101P 2001-05-15 2001-05-15
US60/291,181 2001-05-15
US29124301P 2001-05-16 2001-05-16
US60/291,243 2001-05-16
US29220101P 2001-05-18 2001-05-18
US60/292,001 2001-05-18
US29237401P 2001-05-21 2001-05-21
US60/292,374 2001-05-21
US29258701P 2001-05-22 2001-05-22
US60/292,587 2001-05-22
US29310701P 2001-05-23 2001-05-23
US60/293,107 2001-05-23
US29374701P 2001-05-25 2001-05-25
US60/293,747 2001-05-25
US29410901P 2001-05-29 2001-05-29
US29411001P 2001-05-29 2001-05-29
US60/294,109 2001-05-29
US60/294,110 2001-05-29
US29443401P 2001-05-30 2001-05-30
US60/294,434 2001-05-30
US29482701P 2001-05-31 2001-05-31
US60/294,827 2001-05-31
US30487901P 2001-07-12 2001-07-12
US60/304,879 2001-07-12
US30890101P 2001-07-31 2001-07-31
US60/308,901 2001-07-31
US31227001P 2001-08-14 2001-08-14
US60/312,270 2001-08-14
US31341601P 2001-08-17 2001-08-17
US60/313,416 2001-08-17
US31846301P 2001-09-10 2001-09-10
US60/318,463 2001-09-10
US32568301P 2001-09-27 2001-09-27
US60/325,683 2001-09-27
US33029201P 2001-10-18 2001-10-18
US60/330,292 2001-10-18
US33387301P 2001-11-28 2001-11-28
US60/333,873 2001-11-28
US33690901P 2001-12-03 2001-12-03
US33755201P 2001-12-03 2001-12-03
US60/336,909 2001-12-03
US60/337,552 2001-12-03
US60/359,245 2002-02-21
US10/136,826 2002-05-01

Publications (2)

Publication Number Publication Date
WO2003010327A2 WO2003010327A2 (en) 2003-02-06
WO2003010327A3 true WO2003010327A3 (en) 2003-12-24

Family

ID=27586854

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/014199 Ceased WO2003010327A2 (en) 2001-02-21 2002-05-02 Novel proteins and nucleic acids encoding same

Country Status (1)

Country Link
WO (1) WO2003010327A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL155653A0 (en) 2000-12-20 2003-11-23 Bristol Myers Squibb Co Polynucleotides encoding human phosphatases
DK1573022T3 (en) 2001-04-10 2011-09-12 Agensys Inc Nucleic acid and corresponding protein designated 184P1E2 suitable for the treatment and detection of cancer
MXPA03010052A (en) 2001-05-03 2004-04-02 Akzo Nobel Nv Peptidylarginine deiminase 6.
WO2004050007A2 (en) * 2002-11-29 2004-06-17 Develogen Ag Mammalian bt-42 proteins involved in the regulation of energy homeostasis
CA2518101A1 (en) * 2003-03-03 2005-06-09 Genentech, Inc. Compositions and methods for the treatment of systemic lupus erythematosis
US20050281800A1 (en) 2004-06-16 2005-12-22 Glen Gong Targeting sites of damaged lung tissue
US7608579B2 (en) 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US7553810B2 (en) 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
JP5113519B2 (en) 2004-07-08 2013-01-09 ヌームアールエックス・インコーポレーテッド Treatment device, treatment method and material for pleural effusion
GB201001444D0 (en) * 2010-01-29 2010-03-17 Cambridge Entpr Ltd Biomarkers
MY199259A (en) 2015-03-17 2023-10-23 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
GB201504502D0 (en) * 2015-03-17 2015-04-29 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
CR20200525A (en) 2015-06-19 2020-12-23 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers
GB201510771D0 (en) 2015-06-19 2015-08-05 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHOU C.F. ET AL.: "Identification of a keratin-associated protein that localizes to a membrane compartment", BIOCHEM. J., vol. 298, no. 2, January 1994 (1994-01-01), pages 457 - 463 *
DATABASE GENBANK [online] US NATIONAL LIBRARY OF MEDICINE, (BETHESDA, MD, USA); May 2000 (2000-05-01), BIRREN ET AL., XP002969836, Database accession no. (AC025904) *
LIAO J. ET AL.: "Association of glucose-regulated protein (grp78) with human keratin 8", FEBS LETT., vol. 417, no. 3, January 1997 (1997-01-01), pages 316 - 320, XP004261474 *

Also Published As

Publication number Publication date
WO2003010327A2 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
WO2003000842A3 (en) Novel proteins and nucleic acids encoding same
WO2002081498A3 (en) Novel proteins and nucleic acids encoding same
WO2003010327A3 (en) Novel proteins and nucleic acids encoding same
WO2003040325A3 (en) Novel proteins and nucleic acids encoding same
WO2001036645A3 (en) Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
WO2002072757A3 (en) Novel proteins and nucleic acids encoding same
WO2000053742A3 (en) Polynucleotides and proteins encoded thereby
WO2001049729A8 (en) Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use
WO2003083046A3 (en) Novel proteins and nucleic acids encoding same
WO2003023001A3 (en) Novel proteins and nucleic acids encoding same
WO2003029424A3 (en) Novel proteins and nucleic acids encoding same
WO2003064628A3 (en) Novel proteins and nucleic acids encoding same
WO2001074856A3 (en) Wnt-7b-like polypeptides and nucleic acids encoding same
WO2003102159A3 (en) Novel proteins and nucleic acids encoding same
WO2002002625A3 (en) Novel fibroblast growth factors and nucleic acids encoding same
WO2003025147A3 (en) Novel polynucleotides and proteins encoded thereby
WO2001062928A3 (en) Polypeptides and nucleic acids encoding same
WO2001070978A3 (en) Polypeptides and nucleic acids encoding same
WO2000061754A3 (en) Human proteins and polynucleotides encoding them
WO2001061009A3 (en) Polypeptides and nucleic acids encoding same
WO2001044473A3 (en) Polypeptides and nucleic acids encoding same
WO2004048512A3 (en) Novel proteins and nucleic acids encoding same
WO2001036638A8 (en) Polypeptides and nucleic acids encoding same
WO2003057854A3 (en) Novel proteins and nucleic acids encoding same
WO2003076642A3 (en) Novel proteins and nucleic acids encoding same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US US US US US US US

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE CH CY DE DK FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP